Novel Biomarkers and Therapeutic Strategies in Nephropathy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 September 2024 | Viewed by 21
Special Issue Editors
Interests: clinical nephrology; hemodialysis; kidney transplantation; dialysis; chronic renal failure; transplantation; renal; kidney; chronic kidney failure; peritoneal dialysis; renal disease; kidney disease; fibrosis; transplant immunology and translational research
Special Issues, Collections and Topics in MDPI journals
Interests: translational research in nephrology; transplant medicine; kidney disease; renal disease
Special Issue Information
Dear Colleagues,
We kindly invite you to contribute to the Special Issue “Novel Biomarkers and Therapeutic Strategies in Nephropathy”. The traditional biomarkers used in clinical practice for assessing kidney function (e.g., GFR, serum creatinine, proteinuria) have the limitation that they increase when the damage is advanced. The early identification of kidney damage by one or multiple specific biomarkers is an important unmet need in nephrology to prevent disease progression, select the most effective therapy, and improve patient survival. In addition, researching suitable biomarkers may help researchers identify new potential therapeutic targets and drugs.
In recent years, the advances in molecular biology techniques with the development of molecular analysis of biopsy samples, liquid biopsy, advances in second-generation sequencing, and multi-omics technologies combined with progress in computational bioinformatics, artificial intelligence, and systems biology have pushed forward the research in this field. In the future, integrating novel identified biomarkers with clinical practice will lead to the development of personalized medicine.
Original articles and comprehensive reviews that focus on this area of research are welcome. Since IJMS is a journal of molecular science, pure clinical or model studies will not be suitable for our journal. However, clinical or pure model submissions with biomolecular experiments are welcome.
Prof. Dr. Gianluigi Zaza
Dr. Simona Granata
Dr. Michele Provenzano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prognostic biomarkers
- kidney diseases
- predictive biomarkers
- nephrology
- rare diseases
- glomerulonephritis
- epidemiology
- translational research
- biomarkers
- omics
- transcriptomics
- proteomics
- metabolomics
